SCHEMBL29890913

SCHEMBL29890913

C=Cc1cccc2c1Sc1ccccc1S2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
ALOX5 P09917 1/20 0.40
MAOA P21397 2/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
BCHE P06276 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32
CNR1 P21554 1/20 0.32
ACHE P22303 1/20 0.32
PTGS1 P23219 1/20 0.32
SLC6A2 P23975 1/20 0.32
HTR2C P28335 1/20 0.32
PTGS2 P35354 1/20 0.32
SNCA P37840 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3046459 1.00 ALDH1A1 (0.40) ALDH1A1ALOX5MAOAMEN1CYP1A2
SCHEMBL4795404 0.94
SCHEMBL9934437 0.79 KMT2A (0.48) ALDH1A1ALOX5MAOAMEN1CYP1A2
SCHEMBL19838275 0.79 ALOX5 (0.33) ALDH1A1ALOX5
SCHEMBL28275464 0.77 ALOX5 (0.33) ALDH1A1ALOX5
SCHEMBL7875601 0.72 GABRA1 (0.44) ALDH1A1ALOX5MEN1GAAMAPT
SCHEMBL9935082 0.71 ALOX5 (0.43) ALOX5MAOAMEN1CYP1A2BCHE
SCHEMBL1176773 0.71 ALDH1A1 (0.60) ALDH1A1MEN1KMT2ATDP1TSHR
SCHEMBL3078569 0.70 ALOX5 (0.66) ALDH1A1ALOX5MAOAMEN1CYP1A2
SCHEMBL30320186 0.70 ALOX5 (0.66) ALDH1A1ALOX5MAOAMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240425474-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-12-26 US claimed
EP-4367098-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP Studiengesellschaft Kohle gGmbH (DE) 2024-05-15 EP claimed
WO-2023280638-A9 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-01-18 WO claimed
WO-2023280638-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE MBH (DE) 2023-01-12 WO claimed
EP-4112600-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP Studiengesellschaft Kohle mbH (DE) 2023-01-04 EP claimed
US-20240425474-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-12-26 US disclosed
US-20240425474-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-12-26 US disclosed
US-20240425474-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-12-26 US disclosed
EP-4367098-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP Studiengesellschaft Kohle gGmbH (DE) 2024-05-15 EP disclosed
EP-4367098-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP Studiengesellschaft Kohle gGmbH (DE) 2024-05-15 EP disclosed
EP-4367098-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP Studiengesellschaft Kohle gGmbH (DE) 2024-05-15 EP disclosed
EP-4313156-A1 DISULFIDE-BASED PRODRUG COMPOUNDS Ludwig-Maximilians-Universität München (DE) 2024-02-07 EP disclosed
WO-2023280638-A9 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-01-18 WO disclosed
WO-2023280638-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE MBH (DE) 2023-01-12 WO disclosed
WO-2023280638-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE MBH (DE) 2023-01-12 WO disclosed
WO-2023280638-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE MBH (DE) 2023-01-12 WO disclosed
EP-4112600-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP Studiengesellschaft Kohle mbH (DE) 2023-01-04 EP disclosed
EP-4112600-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP Studiengesellschaft Kohle mbH (DE) 2023-01-04 EP disclosed
EP-4112600-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP Studiengesellschaft Kohle mbH (DE) 2023-01-04 EP disclosed
WO-2022200347-A1 DISULFIDE-BASED PRODRUG COMPOUNDS LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2022-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425474-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP TRRAP, TST, TERB1 ALDH1A1 1671/4885ALOX5 1158/4885MAOA 899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.